World Stem Cell Summit
  • About WSCS
    • About Us
    • Past Speakers
    • Annual Regenerative Medicine Essentials Course
    • 2023 Public Day
    • Symposium Intersection of RegMed & Healthspan
    • Effective Patient Advocacy
    • Regenerative Medicine & the Commercial Space Economy
    • Hot Topics in 2023 at World Stem Cell Summit
  • Partners/Sponsors
    • Partners/Sponsors
    • Sponsorship Opportunities
  • Upcoming Events
  • News & Media
    • News and Opinions
    • WSCS 2023 Photos
    • WSCS Video
  • Contact Us
Select Page

NSU Cardiac Research Project

by admin | Dec 18, 2017 | Bernie Siegel’s WORLD STEM CELL SUMMIT BLOG, News and Opinions

NSU Researchers Investigate Stem Cells as Better Option for Patients with Heart Disease

Heart disease is the leading cause of death for both men and women. Currently, heart transplants are the only treatment option for patients with significant damaged heart tissue typically caused by a heart attack – a method that is costly, difficult to secure a match and subject to additional major health complications following surgery . . .

(click here to read more on NSU’s website)

NSU_cardiac_research

More Posts from News Feed

  • heart-image–750×500
    Accelerating cardiac regenerative therapy with HiPSC…
  • blue-cells-bg-1200
    Stem Cell Research on Global Stage in Texas
  • Sanford-Medical-Center-Fargo_future-plans_Aerial1
    Sanford Health - FDA approves safety of ongoing stem…

Recent Posts

  • Scientists discover how hair cells can help heal skin faster
  • Engineered Bone Marrow Model Advances CRISPR-CAR T Research in AML
  • Stem Cells Prevent Heart Failure After Heart Attack
  • We need to start thinking of AI as “normal”
  • Anti-fibrotic effect of human amniotic fluid stem cells in biliary epithelial-mesenchymal transition of liver ductal organoid
  • Stanford makes stem cell transplants safer without chemo
World Stem Cell Summit Logo - White version
Copyright © 2025 Regenerative Medicine Foundation, All rights reserved.
  • Follow
  • Follow
  • Follow
  • Follow
  • Follow